Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;4(6):1128-35.
doi: 10.2215/CJN.00260109. Epub 2009 May 14.

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

Daniela Veit Barreto  1 , Fellype Carvalho Barreto, Sophie Liabeuf, Mohammed Temmar, Francis Boitte, Gabriel Choukroun, Albert Fournier, Ziad A Massy
Affiliations

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

Daniela Veit Barreto et al. Clin J Am Soc Nephrol. 2009 Jun.

Abstract

Background and objectives: Cardiovascular disease is the main cause of mortality in chronic kidney disease (CKD) patients. Vitamin D might have beneficial effects on vascular health. The aim of this study was to determine the prevalence of vitamin D deficiency (25-hydroxyvitamin D [25D] <or= 15 ng/ml) and insufficiency (25D levels between 16 and 30 ng/ml) in a cohort of patients at different CKD stages and the relationships between vitamin D serum levels, vascular calcification and stiffness, and the mortality risk.

Design, setting, participants & measurements: One hundred forty CKD patients (85 men, mean age 67 +/- 12 yr; CKD stages 2 [8%], 3 [26%], 4 [26%], 5 [7%], and 5D [(33%]) were allocated for a prospective study. Serum levels of 25D and 1,25-dihydroxyvitamin D, aortic calcification score, and pulse wave velocity (PWV) were evaluated.

Results: There was a high prevalence of vitamin D deficiency (42%) and insufficiency (34%). Patients with 25D <or= 16.7 ng/ml (median) had a significantly lower survival rate than patients with 25D >16.7 ng/ml (mean follow-up, 605 +/- 217 d; range, 10 to 889; P = 0.05). Multivariate adjustments (included age, gender, diabetes, arterial pressure, CKD stage, phosphate, albumin, hemoglobin, aortic calcification score and PWV) confirmed 25D level as an independent predictor of all-cause mortality.

Conclusions: Vitamin D deficiency and insufficiency were highly prevalent in this CKD cohort. Low 25D levels affected mortality independently of vascular calcification and stiffness, suggesting that 25D may influence survival in CKD patients via additional pathways that need to be further explored.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A) Serum levels of 25-hydroxyvitamin D (25D) and (B) serum levels of 1,25-dihydroxyvitamin D (1,25D) as a function of CKD stage (with dashed lines indicating the reference values). *P < 0.05 for CKD stage 5D versus other groups.
Figure 2.
Figure 2.
Crude patient survival as a function of vitamin D (25D) levels (≤16.7 ng/ml or >16.7 ng/ml).
See this image and copyright information in PMC

References

    1. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266–281, 2007 - PubMed
    1. Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL, Adams JS: Extra-renal 25-hydroxyvitamin D3–1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103: 316–321, 2007 - PubMed
    1. Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662–687, 2005 - PubMed
    1. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229–238, 2002 - PMC - PubMed
    1. Banerjee P, Chatterjee M: Antiproliferative role of vitamin D and its analogs–A brief overview. Mol Cell Biochem 253: 247–254, 2003 - PubMed

Publication types

MeSH terms